Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hohlfeld

Showing results (151-160 of 206) with videos related to

Pageof 21
Sort By:
Journal of Neurology|November 14, 2008
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations, H Wiendl, K V Toyka, et al.
Deutsche Medizinische Wochenschrift (1946)|June 12, 1999
[Therapy of multiple sclerosis]B Bereznai, N Goebels, T Dang, et al.
Brain : a Journal of Neurology|November 5, 1999
Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoproteinR B Lindert, C G Haase, U Brehm, et al.
Neurology|October 1, 1983
Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severityU A Besinger, K V Toyka, M Hömberg, et al.
Neurology|November 26, 2008
Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 casesT Kümpfel, L-A Hoffmann, H Pellkofer, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Acetylcholine receptor-specific human T-lymphocyte linesR Hohlfeld, K V Toyka, M Michels, et al.
Annals of Neurology|December 1, 1988
Myasthenia gravis: discontinuation of long-term azathioprineM Michels, R Hohlfeld, H P Hartung, et al.
Brain : a Journal of Neurology|April 5, 2001
Treatment of multiple sclerosis with Copaxone (COP): Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cellsC Farina, F Then Bergh, H Albrecht, et al.
The Journal of Clinical Investigation|March 1, 1988
Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravisR Hohlfeld, K V Toyka, L L Miner, et al.
Muscle & Nerve|May 1, 1986
Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab')2 hybrid moleculesR Sterz, R Hohlfeld, K Rajki, et al.
Pageof 21

Showing results (151-160 of 206) with videos related to

Sort By:
Pageof 21
Journal of Neurology|November 14, 2008
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations, H Wiendl, K V Toyka, et al.
Deutsche Medizinische Wochenschrift (1946)|June 12, 1999
[Therapy of multiple sclerosis]B Bereznai, N Goebels, T Dang, et al.
Brain : a Journal of Neurology|November 5, 1999
Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoproteinR B Lindert, C G Haase, U Brehm, et al.
Neurology|October 1, 1983
Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severityU A Besinger, K V Toyka, M Hömberg, et al.
Neurology|November 26, 2008
Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 casesT Kümpfel, L-A Hoffmann, H Pellkofer, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Acetylcholine receptor-specific human T-lymphocyte linesR Hohlfeld, K V Toyka, M Michels, et al.
Annals of Neurology|December 1, 1988
Myasthenia gravis: discontinuation of long-term azathioprineM Michels, R Hohlfeld, H P Hartung, et al.
Brain : a Journal of Neurology|April 5, 2001
Treatment of multiple sclerosis with Copaxone (COP): Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cellsC Farina, F Then Bergh, H Albrecht, et al.
The Journal of Clinical Investigation|March 1, 1988
Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravisR Hohlfeld, K V Toyka, L L Miner, et al.
Muscle & Nerve|May 1, 1986
Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab')2 hybrid moleculesR Sterz, R Hohlfeld, K Rajki, et al.
Pageof 21